Multifaceted role of RNA editing in promoting loss-of-function of PODXL in cancer

• DOI: 10.1016/j.isci.2022.104836
• Publication Date: 2022-08-02T08:58:46Z
• Authors: Ting Fu; Tracey W. Chan; Jae Hoon Bahn; Tae-Hyung Kim; Amy C. Rowat; Xinshu Xiao
• Keywords: 0303 health sciences; Science; Human Genome; Q; 610; bioinformatics; Biological Sciences; Article; omics; 3. Good health; Biological sciences; 03 medical and health sciences; Cancer Genomics; Rare Diseases; 616; Genetics; cancer; Biochemistry and Cell Biology; Cancer

PODXL, a protein that is dysregulated in multiple cancers, plays an important role in promoting cancer metastasis. In this study, we report that RNA editing promotes the inclusion of a PODXL alternative exon. The resulting edited PODXL long isoform is more prone to protease digestion and has the strongest effects on reducing cell migration and cisplatin chemoresistance among the three PODXL isoforms (short, unedited long, and edited long isoforms). Importantly, the editing level of the PODXL recoding site and the inclusion level of the PODXL alternative exon are strongly associated with overall patient survival in Kidney Renal Clear Cell Carcinoma (KIRC). Supported by significant enrichment of exonic RNA editing sites in alternatively spliced exons, we hypothesize that exonic RNA editing sites may enhance proteomic diversity through alternative splicing, in addition to amino acid changes, a previously under-appreciated aspect of RNA editing function.